Nitika Mor | Drug Discovery and Development | Best Researcher Award

Published on by Top Pharmaceutical

Nitika Mor | Drug Discovery and Development | Best Researcher Award

Dr. Nitika Mor, Baba Mastnath University, Asthal Bohar, Rohtak (HR), India

Dr. Nitika Mor is an accomplished Assistant Professor of Chemistry at Baba Mastnath University, Rohtak, with a Ph.D. in Pharmaceutical Chemistry from Kurukshetra University. Her research focuses on drug delivery systems, traditional medicinal formulations, and molecular docking. She has published 14 research papers, authored a book chapter, holds two patent publications (one granted), and has received multiple awards including the UGC-CSIR JRF/SRF and Best Poster Award. With technical expertise in synthesis, biological assays, and in-silico studies, Dr. Mor is a dynamic contributor to pharmaceutical research and innovation.

Publication Profile

Google Scholar

Education

Dr. Nitika Mor is a dedicated researcher with a Ph.D. in Chemistry from Kurukshetra University (2017–2022), where she focused her thesis on the Design, Characterization, and In-Vitro Studies of Sustained Release Delivery Systems for Curcumin under the guidance of Dr. Neera Raghav. 🎓 She holds an M.Sc. in Organic Chemistry (2013–2015) from Hindu College, Sonipat, affiliated with Maharishi Dayanand University, Rohtak. 🧪 Her academic journey began with a B.Sc. in Physics, Chemistry, and Mathematics (2010–2013) from Hindu Girls College, Sonipat. 📚 Dr. Mor’s educational background reflects a strong foundation in science and innovative pharmaceutical research.

Experience

Dr. Nitika Mor is currently serving as an Assistant Professor in the Department of Chemistry at Baba Mastnath University, Rohtak, since February 1, 2023. 🏛️ With her strong academic foundation and research expertise in pharmaceutical and organic chemistry, she brings innovative teaching methods and deep subject knowledge to the classroom. 🧪 Her role involves mentoring students, delivering engaging lectures, and contributing to the academic growth of the department. 📚 Dr. Mor’s commitment to education and passion for chemistry make her a valuable asset to the university’s faculty. ✨ She continues to inspire budding scientists through her teaching and guidance.

Awards

Dr. Nitika Mor has received several prestigious awards and fellowships in recognition of her academic excellence and research potential. She qualified the UGC-CSIR JRF (Chemical Sciences) in June 2016 with an impressive All India Rank of 65. 🇮🇳 She was awarded the Junior Research Fellowship (JRF) from October 2017 to September 2019, followed by the Senior Research Fellowship (SRF) from October 2019 to March 2022 by UGC-CSIR India to support her Ph.D. journey. 🔬 In 2018, she received the Best Poster Presentation Award at the 9th National Conference on RACES-2018 held at MMM College, Patiala, Punjab.

Research Focus

Dr. Nitika Mor specializes in pharmaceutical and biomedical sciences, with a strong research focus on natural polymer-based oral drug delivery systems. Her work emphasizes the use of biopolymers like cellulose, pectin, carrageenan, and alginate for sustained release formulations, particularly for curcumin. She explores modifications of polysaccharides and curcumin derivatives to improve bioavailability, pharmacokinetics, and therapeutic efficacy. Her contributions also span phytochemistry, investigating medicinal plants like Ashwagandha and Garlic for their pharmacological benefits. Dr. Mor integrates green chemistry, molecular modeling, and clinical insights into her innovative drug delivery strategies.

Publication Top Notes

Recent advances in cellulose, pectin, carrageenan and alginate-based oral drug delivery systems

Some cetyltrimethylammonium bromide modified polysaccharide supports as sustained release systems for curcumin

Design and development of carboxymethylcellulose ester of curcumin as sustained release delivery system in liver

Synthesis of propynyloxy substituted some novel aurones as potent cathepsin B inhibitors

Alginate hydrogels: Sustained release system to analyze the effect of traditional excipients on curcumin availability

Study on enhanced serum protein protecting and anti-cathepsin activities of various curcumin formulations containing traditional excipients and bio-enhancers

In-vitro simulation of modified-alginate ester as sustained release delivery system for curcumin

Curcumin, the panacea: A review on advancement to solve pharmaco-kinetic problems.

A review: Phytochemicals and bioactivities of Ashwagandha (Withania somnifera).

Azhagu Madhavan | Pharmaceutical Analysis | Excellence in Research

Published on by Top Pharmaceutical

Azhagu Madhavan | Pharmaceutical Analysis | Excellence in Research

Dr. S. Azhagu Madhavan, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences, Tamil Nadu, India

Dr. S. Azhagu Madhavan, M.Sc., Ph.D., is an Assistant Professor at Saveetha Medical College and Hospital, Chennai, India. His academic background spans Zoology and Biotechnology, with a focus on pharmacology, pharmacognosy, phytochemistry, and nanotechnology. His Ph.D. research explored the pharmacological effects of Costus Spicatus in diabetic rats. He has several patents, including innovations in biosensors and biodegradable products. Dr. Madhavan has contributed to high-impact journals in neuroscience, immunology, and nanobiotechnology. He is passionate about advancing natural products and nanobiotechnology for healthcare and environmental applications.

Publication Profile

Google Scholar

Education

Dr. S. Azhagu Madhavan is an accomplished academic with a strong foundation in Zoology and Biotechnology. He earned his Ph.D. in Zoology from A Veeriya Vandayar Memorial Sri Pushpam College (an autonomous institution affiliated with Bharathidasan University) in Poondi, Thanjavur, Tamil Nadu, India, from 2016 to 2020. His academic journey began with a Master’s in Zoology (2014-2016) followed by a Bachelor’s in Zoology and Biotechnology (2011-2014), both from the same esteemed institution. Dr. Madhavan’s educational background reflects his deep passion for biological sciences and commitment to advancing knowledge in his field.

Experience

Dr. S. Azhagu Madhavan has accumulated valuable experience in the academic and research fields. He is currently serving as an Assistant Professor at Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai, since 2022. Previously, he worked as a Research Associate at Global Scientific Research Services, Ariyalur (2020-2021), and as a Research Assistant at Harman Institute of Science Education and Research, Thanjavur (2016-2017). With a total of 4 years and 8 months of experience, Dr. Madhavan has significantly contributed to the field of biological sciences.

Awards

Dr. S. Azhagu Madhavan has made notable contributions to the scientific community through his oral presentations. One of his significant presentations, titled “Earthworm Cut of Bacteria and Fungus Analysis Eisenia fetida,” was delivered at the National Conference on Trends in Healthcare and Biotechnology in 2016. In addition to this, he was invited as a speaker for the event Opportunities & Challenges (THBOC-2016), organized by the P.G & Department of Zoology and Biotechnology, A.V.V.M Sri Pushpam College. His ongoing efforts continue to impact the field of healthcare and biotechnology.

Research Focus

Dr. S. Azhagu Madhavan’s research primarily focuses on phytochemistry, nanotechnology, and medicinal plants. His studies include phytochemical screening, GC-MS analysis, and green synthesis of nanoparticles from various plant extracts such as Silybum marianum, Murraya koenigii, and Avicennia marina. He explores the bioactive compounds in these plants for their antioxidant, anticancer, antibacterial, and antidiabetic properties. His work on silver nanoparticles also highlights their potential applications in biomedical sciences. His contributions significantly impact areas like pharmacology and nanomedicine.

Publication Top Notes

Phytochemical screening and GC-MS analysis of bioactive compounds present in ethanolic leaves extract of Silybum marianum (L).

Potential of banana based cellulose materials for advanced applications: A review on properties and technical challenges

Green synthesis and characterization of silver nanoparticles with different solvent extracts of Sesbania grandiflora (L.) Poiret and assessment of their antibacterial …

Phytochemical screening and GC–MS analysis of bioactive compounds present in ethanolic leaf extract Murraya koenigii

Polyphenol-compounds From Green Synthesis of Antimicrobial property of Silver Nanoparticles using Eichhornia crassipes: Characterization and Applications

Phytochemical screening and comparative gc–ms analysis of bioactive compounds present in methanolic leaf and latex extract Calotropis gigantea (L)

Extraction, biosynthesis, and characterization of silver nanoparticles for its enhanced applications of antibacterial activity using the Silybum marianum Linn. plant

Identification and characterization of silver nanoparticles from Erythrina indica and its antioxidant and Uropathogenic antimicrobial properties

Anticancer activity of Pedalium murex linn methanolic leaves extract against A549 human lung cancer cell line

Wei Chen | Pharmacology | Best Researcher Award

Published on by Top Pharmaceutical

Wei Chen | Pharmacology | Best Researcher Award

Prof. Wei Chen, Fudan University, China

Prof. Wei Chen is an Associate Professor at Fudan University, specializing in neuroscience and pharmacology. He earned his Ph.D. in Pharmacy from Fudan University and completed postdoctoral research at Stanford University. His work focuses on neuroregeneration, metabolic reprogramming, and precision medicine, with numerous high-impact publications in Nature Communications, Phytomedicine, and Advanced Biology. Prof. Chen has received multiple prestigious awards, including the National Scholarship and the Excellence Award at the International Forum of Precision Medicine. His innovative contributions span both basic research and clinical applications in neuropharmacology and renal therapy.

Publication Profile

Orcid

Education

Prof. Wei Chen 🧠💊 is an esteemed Associate Professor at Fudan University, Shanghai, China, serving since September 2022. Prior to this, he was a Postdoctoral Scholar in Neuroscience at Stanford University, Palo Alto, USA (2019–2022), where he advanced cutting-edge research in brain science. Prof. Chen earned his Ph.D. in Pharmacy from Fudan University in 2019, following his M.D. in Pharmacy from the Second Military Medical University (2016) and Anhui Medical University (2013). With a solid foundation in pharmaceutical sciences and neuroscience, his academic journey reflects a commitment to innovation, discovery, and excellence in health research and education 🌍📚.

Awards

Prof. Wei Chen 🏅🎓 has been recognized with numerous prestigious awards and fellowships throughout his academic journey. In 2019, he was honored as one of the Excellent Graduates in Shanghai and received the “Warm Heart” Scholarship 💖. He earned the esteemed National Scholarship twice, in both 2018 and 2017, acknowledging his outstanding academic performance 📘. He also received the Excellence Award at the 2017 International Academic and Industrial Forum of Precision Medicine 🧬. Earlier, he was awarded the Best Student Award in 2016 🥇 and secured third prize in the Million College Students Science Entrepreneurship Competition in Anhui Province in 2012 💡🏆.

Research Focus

Wei Chen is a prominent researcher with a diverse focus on biomedicine, molecular therapy, and gene therapy. His work primarily explores the treatment of neurodegenerative disorders, kidney injury, liver disease, and cancer. He specializes in immune modulation, particularly through interleukin-22 (IL-22), and metabolic reprogramming to treat various diseases. His research also delves into neuroprotection, cellular regeneration, and inflammatory responses, utilizing innovative approaches like gene delivery and nanoparticle therapy. His contributions aim to transform therapeutic strategies, especially in complex conditions like pancreatic cancer and neurodegeneration.

Publication Top Notes

Qingyihuaji Formula reprograms metabolism to suppress pancreatic cancer growth and progression through LINC00346-OMA1-ATF4 signaling

Notoginsenoside Fc, a novel renoprotective agent, ameliorates glomerular endothelial cells pyroptosis and mitochondrial dysfunction in diabetic nephropathy through regulating HMGCS2 pathway

Maprotiline restores ER homeostasis and rescues neurodegeneration via Histamine Receptor H1 inhibition in retinal ganglion cells

The role of interleukin-22 in lung health and its therapeutic potential for COVID-19.

VEGF-B antibody and interleukin-22 fusion protein ameliorates diabetic nephropathy through inhibiting lipid accumulation and inflammatory responses

Interleukin-22 mediated renal metabolic reprogramming via PFKFB3 to treat kidney injury
Interleukin-22 ameliorated acetaminophen-induced kidney injury by inhibiting mitochondrial dysfunction and inflammatory responses
Gene therapy for neurodegenerative disorders: advances, insights and prospects

Mario Leporace | Personalized Medicine | Best Innovation Award

Published on by Top Pharmaceutical

Mario Leporace | Personalized Medicine | Best Innovation Award

Prof. Dr. Mario Leporace, Hospital and University, Italy

Prof. Dr. Mario Leporace is a distinguished Clinical Radiologist at the Department of Nuclear Medicine and Theragnostics, “Mariano Santo” Hospital, Cosenza, Italy. With expertise in oncologic imaging, hybrid and molecular imaging, and cardiovascular radiology, he is renowned for his advanced diagnostic work using X-ray, CT, MRI, PET/CT, and SPECT/CT. He holds a Master’s in Interventional Oncology and has contributed to over 15 peer-reviewed publications. His professional journey spans top institutions in Rome and Cosenza, marking a career dedicated to innovation in radiology and nuclear medicine.

Publication Profile

Scopus

Education

Prof. Dr. Mario Leporace 🎓 is a distinguished expert in interventional oncology and radiology. In 2022, he earned a Master’s Degree in Interventional Oncology from Fondazione Policlinico Universitario A. Gemelli IRCCS in Rome, with a thesis on thermal ablation of bone metastases 🔥🦴. From 2001 to 2005, he completed his post-graduate certification in Radiology at the University of Rome “Tor Vergata” 🏥, graduating cum laude with a thesis on hybrid imaging 🧠📸. He also obtained his Degree in Medicine and Surgery from the same university (1995–2001), graduating with top honors and a thesis in vascular imaging 🫀🧬.

Experience

Prof. Dr. Mario Leporace 🩺 has an extensive career in radiology and nuclear medicine, showcasing over two decades of dedicated medical service. Since October 2017, he has been serving in the Department of Nuclear Medicine and Theragnostics at “Mariano Santo” Hospital in Cosenza, Italy ⚛️🏥. From May 2016 to September 2017, he worked at the Department of Radiology, “Annunziata” Hospital 🏨. Earlier, from March 2006 to April 2016, he contributed to the European Hospital in Rome, and concurrently, from November 2005 to April 2016, served at the Aurelia Hospital in Rome 🏛️🔬, strengthening his clinical expertise across institutions.

Research Focus

Prof. Dr. Mario Leporace focuses his research on Thermal Ablation with Magnetic Resonance-guided Focused Ultrasound Surgery (MRgFUS) 🔬🧠. His work bridges medical physics and oncological applications, exploring non-invasive treatments that use focused ultrasound energy to thermally ablate tumors with MRI precision guidance 🎯. This technique offers cutting-edge therapeutic possibilities in fields such as oncology, neurology, and women’s health 🧬💡. Prof. Leporace’s contributions advance both the clinical outcomes and technological innovation of MRgFUS, making him a key figure in image-guided therapy, minimally invasive surgery, and cancer treatment research .

Publication Top Notes

The Thermal Ablation with MRgFUS: From Physics to Oncological Applications

Minjian Chen | Pharmacodynamics | Best Researcher Award

Published on by Top Pharmaceutical

Minjian Chen | Pharmacodynamics | Best Researcher Award

Prof. Dr. Minjian Chen, Nanjing Medical University, China

Prof. Dr. Minjian Chen is a distinguished toxicologist and professor at Nanjing Medical University. He earned his Ph.D. in Toxicology (2013) and has led pioneering research on male infertility and birth defects using metabolomics and exposomics. He has completed over 10 major research projects, including NSFC and China’s National Key R&D programs, and holds 4 national patents. Recognized in Jiangsu’s “Qinglan Project,” he has international experience, including research at the U.S. NIEHS. With an H-index of 36, Prof. Chen is a rising leader in environmental health science and precision diagnostics.

Publication Profile

Scopus

Education

Prof. Dr. Minjian Chen 🎓 earned his Bachelor’s degree in Preventive Medicine (2003–2008) and Ph.D. in Toxicology (2008–2013) from Nanjing Medical University (NMU). He completed postdoctoral training (2013–2018) at NMU’s School of Basic Medicine and was selected for the China–Australia Young Scientist Exchange Program in 2014 🌏. From 2019 to 2020, he served as a guest researcher at the U.S. National Institute of Environmental Health Sciences (NIEHS), NIH 🧪. Appointed as a Lecturer in 2013 and promoted to Professor in 2023 at NMU, he is honored as an Outstanding Young Backbone Teacher under Jiangsu’s “Qinglan Project” and a Distinguished Young Academic Leader 🌟.

Professional Memberships

Prof. Dr. Minjian Chen 🧑‍🔬 holds several prominent positions in the scientific community. He serves as the Vice Secretary-General of the Evidence-based Toxicology Professional Committee with the Chinese Society of Toxicology ⚖️. As an Executive Member of the Third Youth Committee of the same society, he actively contributes to advancing toxicology research. He is also a member of the Fertility Preservation and Restoration Professional Committee with the China Association of Obstetrics and Gynecology 👶. Additionally, he is part of multiple professional committees, including the Mutagenesis Professional Committee and the Jiangsu Provincial Preventive Medicine Association 🌱. He is the Vice Chair of the Youth Committee for the Jiangsu Provincial Society of Toxicology.

Research Focus

Prof. Dr. Minjian Chen’s research primarily focuses on metabolomics and environmental toxicology, investigating how chemical exposures disrupt metabolic processes, especially during critical developmental stages. His work includes examining the effects of substances like PFOS (perfluorooctane sulfonate) on embryonic development, exploring metabolic changes in oocyte growth, and understanding spermatogenesis in mice. Dr. Chen also studies pharmacology by analyzing the urate-lowering effects of compounds like delphinidin-3-glucoside. His integrated approach to omics technologies provides insights into how environmental chemicals alter metabolism, offering potential clinical implications. His contributions are crucial for advancing ecotoxicology, metabolic disorders, and biochemical research.

Publication Top Notes

Metabolic characterizations of PFOS-induced disruptions in early embryonic development

Association of Personal Care and Consumer Product Chemicals with Long-Term Amenorrhea: Insights into Serum Globulin and STAT3

Characterization of Metabolic Patterns in Mouse Spermatogenesis and Its Clinical Implications in Humans

Multi-Omics Reveal the Metabolic Changes in Cumulus Cells During Aging

Urate-lowering effect of delphinidin-3-glucoside in red kidney beans via binding to the FAD site of the XO enzyme

Integrative Omics Reveals the Metabolic Patterns During Oocyte Growth

The global phosphorylation landscape of mouse oocytes during meiotic maturation

Environmental Chemical Exposomics and Metabolomics in Toxicology: The Latest Updates

Characterization of metabolic patterns in porcine cumulus cells during meiotic maturation

Exposure to Molybdate Results in Metabolic Disorder: An Integrated Study of the Urine Elementome and Serum Metabolome in Mice

Mert Zeytinoğlu | Clinical Trials | Best Researcher Award

Published on by Top Pharmaceutical

Mert Zeytinoğlu | Clinical Trials | Best Researcher Award

Assoc. Prof. Dr. Mert Zeytinoğlu, Ege University Faculty of Dentistry Department of Oral and Maxillofacial Surgery, Turkey

Assoc. Prof. Dr. Mert Zeytinoğlu is a distinguished academic at Ege University, Faculty of Dentistry, specializing in Oral and Maxillofacial Surgery. With a Ph.D. from Ege University (2004), his research spans oral surgery, clinical sciences, and dental implantology. He has authored over 40 publications, holds an H-index of 3, and has led numerous projects on piezosurgery, wound healing, and dental stem cells. Known for his contributions to surgical techniques and cardiovascular safety in dental anesthesia, Dr. Zeytinoğlu actively mentors postgraduate theses and advances innovative practices in dental science.

Publication Profile

Google Scholar

Education

Assoc. Prof. Dr. Mert Zeytinoğlu began his academic journey at Ege University, where he earned his Bachelor’s degree in Dentistry from the Faculty of Dentistry between 1993 and 1998. His dedication to clinical sciences led him to pursue a Ph.D. in the same institution, specializing in the Department of Clinical Sciences, which he successfully completed between 1999 and 2004. 🇹🇷 Throughout his education, he demonstrated a strong commitment to advancing dental knowledge and practice in Turkey. Dr. Zeytinoğlu’s academic foundation reflects his deep passion for oral health and clinical excellence.

Experience

Assoc. Prof. Dr. Mert Zeytinoğlu has built a distinguished academic career at Ege University’s Faculty of Dentistry. Since 2015, he has been serving as an Associate Professor in the Department of Clinical Sciences, contributing significantly to academic development and clinical training. 🏫 Earlier, from 1999 to 2004, he worked as a Specialist Doctor in the Division of Clinical Sciences, specifically in the Department of Oral and Maxillofacial Surgery, where he gained extensive hands-on experience in complex dental surgeries. 🦷🔬 His academic and clinical roles reflect a deep commitment to excellence in dental education and patient care.

Awards

Assoc. Prof. Dr. Mert Zeytinoğlu received a prestigious award in 2015 for his outstanding research titled “Süt dişi- mesiodens ve daimi molar dişlerin kök hücrelerinin immünohistokimyasal ve histokimyasal yöntemlerle belirlenmesi” (Determination of Stem Cells in Primary, Mesiodens, and Permanent Molar Teeth Using Immunohistochemical and Histochemical Methods). 🧬🦷 His project earned Second Place in the Project Competition of Occupational Organizations during the İzmir Chamber of Dentists Scientific Congress and Exhibition. 🎖️ This recognition highlights his innovative approach to dental research and his contributions to scientific advancement in stem cell applications within oral health.

Research Focus

Assoc. Prof. Dr. Mert Zeytinoğlu primarily focuses on Oral and Maxillofacial Surgery 🦷 and Dental Radiology, with special expertise in the diagnosis and surgical management of jaw pathologies, including cysts, tumors, and bone defects. His research includes the use of fractal analysis 📈, peri-implant bone assessment, and management of impacted third molars, as well as multidisciplinary approaches to benign jaw tumors and dental anomalies. He also investigates the cardiovascular effects of dental anesthetics ❤️, showing interest in dental care for medically compromised patients. His work bridges clinical surgery with diagnostic innovation and patient-centered dental care.

Publication Top Notes

Oral mucosal ulceration: a manifestation of previously undiagnosed pulmonary tuberculosis

Fractal analysis for the assessment of trabecular peri-implant alveolar bone using panoramic radiographs

Effect of tube drainage compared with conventional suturing on postoperative discomfort after extraction of impacted mandibular third molars

Treatment of nonsyndromic dentigerous cysts in primary dentition

Multidisciplinary Management of Benign Jaw Tumors in

Comparison of 2 different flap techniques in the surgical removal of bilateral impacted mandibular third molars

Holter ECG assessment of the effects of three different local anesthetic solutions on cardiovascular system in the sedated dental patients with coronary artery disease/Üç …

Myofibroma of the gingiva: report of a case

Tathagata Adhikary | Herbal Medicine and Nutraceuticals | Best Researcher Award

Published on by Top Pharmaceutical

Tathagata Adhikary | Herbal Medicine and Nutraceuticals | Best Researcher Award

Mr. Tathagata Adhikary, Jadavpur University, India

Dr. Tathagata Adhikary is a dedicated biomedical researcher with a Ph.D. in Biomedical Engineering from Jadavpur University, India. His academic journey spans a Master’s in Biomedical Engineering and a B.Tech in Biotechnology. With extensive research experience supported by prestigious fellowships, he has contributed to nanofertilizers, cancer therapy, and bioremediation. A skilled educator and published scholar, Dr. Adhikary has authored numerous journal articles and conference papers. He also serves as a reviewer for reputed scientific journals and has been invited as a guest speaker on clinical data management. His interdisciplinary approach reflects a passion for innovation in life sciences.

Publication Profile

Google Scholar

Education

Mr. Tathagata Adhikary holds a Ph.D. in Biomedical Engineering from Jadavpur University, India. He earned his Master of Engineering (M.E) in the same field from Jadavpur University (2016–2018) with an impressive CGPA of 8.55/10. 🧬 Prior to that, he completed his B.Tech in Biotechnology from the National Institute of Technology, Durgapur (2012–2016), securing a CGPA of 7.03/10. 📘 His academic journey began at Sudhir Memorial Institute, West Bengal, where he achieved 76.4% in the All India Senior School Certificate Examination (2011), following a strong foundation at Aditya Academy, with 84.5% in his 10th board exams (2009).

Experience

Mr. Tathagata Adhikary has rich research experience, having served as a Senior Research Fellow (June 2022–June 2024) at Jadavpur University, funded by the Department of Higher Education, West Bengal. He was previously a Junior Research Fellow (Aug 2019–Mar 2021) under TEQIP-III and also worked on a NMHS-sponsored project (Aug 2018–July 2019) at NIT Arunachal Pradesh 🌱. In teaching, he conducted practicals and classes in Cell and Molecular Biology for M.E students 🧫 as part of his SRF role at Jadavpur University, contributing to academic excellence with up to six sessions per week 📚.

Awards

Mr. Tathagata Adhikary has made notable academic contributions and achievements. He serves as a reviewer for prestigious journals such as Plant Nano Biology (Elsevier BV) 🧪, Journal of Drug Design and Medicinal Chemistry (Science Publishing Group) 💊, and Technium: Romanian Journal of Applied Sciences and Technology (TechniumScience) ⚙️. He was invited as a guest speaker for a “Value Added Course – Clinical Data Management” organized by Brainware University, India 🎤. Additionally, he qualified the highly competitive GATE 2016 exam in Biotechnology, securing an impressive all-India rank of 822 🏅, demonstrating his academic excellence.

Research Focus

Tathagata Adhikary’s research primarily focuses on interdisciplinary applications in biotechnology, healthcare, and nanotechnology. His work includes studies on phytochemicals, enzyme analysis, oil-water separation, and the biodegradation of pollutants using microbial processes. He also explores the therapeutic potential of natural products like turmeric for wound healing and cancer therapy, emphasizing the integration of computational biology and nanotechnology in drug discovery. His research extends into sustainable practices in agriculture with nanofertilizers and the development of biosensors for healthcare. This diverse body of work contributes to both environmental and health-related innovations.

Publication Top Notes

The internet of things (iot) augmentation in healthcare: An application analytics

Phytochemical analysis and comparative study of antibacterial effect of turmeric extracts using different solvent.

Extraction and separation of oils: the journey from distillation to pervaporation

Enzymes analysis, degradation kinetics, response surface optimization and heavy metal tolerance of the biodegradation of malachite green by Stenotrophomonas koreensis

Cellulases in paper and pulp, brewing and food industries: Principles associated with its diverse applications

Revisiting Therapeutic Potentials of Ethanolic Extract of Curcuma longa L. rhizomes to Evaluate wound Healing Progression upon Topical Application of its Ointment

The paradigm shift towards utilizing nanofertilizers paves a promising future in industrial agriculture and soilless cultivation

Trends in Biosensors and Role of Enzymes as Their Sensing Element for Healthcare Applications

In-silico Approach to Investigate the Phytochemicals of Terminalia arjuna as Multitarget Inhibitors of Proteins Involved with Lung Cancer

Software for Drug Discovery and Protein Engineering: A Comparison Between the Alternatives and Recent Advancements in Computational Biology

Optimization of the Process Parameters to Develop Green‐Synthesized Nanostructures with a Special Interest in Cancer Theranostics

Jameel Al-Tamimi | Biopharmaceutics | Best Researcher Award

Published on by Top Pharmaceutical

Jameel Al-Tamimi | Biopharmaceutics | Best Researcher Award

Dr. Jameel Al-Tamimi, King Saud University, Saudi Arabia

Dr. Jameel Al-Tamimi is a distinguished researcher with a Ph.D. in Immunogenetics from King Saud University, Riyadh, Saudi Arabia. His research focuses on immunology, particularly the role of Killer Immunoglobulin-like Receptors (KIRs) in leukemia. He has expertise in molecular techniques, immunology, and forensic entomology. Dr. Al-Tamimi has published numerous research articles and has contributed to various academic committees. His teaching experience spans courses in molecular biology, human physiology, and medical entomology.

Publication Profile

Google Scholar

Education

Dr. Jameel Al-Tamimi 🎓 is a distinguished researcher with a Ph.D. in Immunogenetics (Excellent 4.9/5) from King Saud University, where his thesis explored the Role of Killer Immunoglobulin-like Receptors (KIRs) with HLA Ligands in Saudi Leukemia Patients 🧬. He also holds an M.Sc. in Entomology and Parasitology (Excellent 4.9/5), investigating the anti-inflammatory effects of Pachycondyla sennaarensis (Samsum Ant) venom in male albino rats 🐜🧪. Dr. Al-Tamimi earned his B.Sc. in Biology (Very Good 89.9/100) from Thamar University, Yemen, with research focused on physiological changes in viral hepatitis (HbsAg and HCV) patients at Thamar Hospital 🧫🦠.

Experience

Dr. Jameel Al-Tamimi 🧑‍🔬 brings a wealth of academic and research experience. Since 2023, he has served on the Scientific Committee for the Researcher Support Program (RSPD) and Research Groups Program (RGP) at the Deanship of Scientific Research 📚. At King Saud University, he contributed to key committees, including labs, academic accreditation, exams, and graduate studies 🏛️. He supervised both the endocrinology and immunology laboratories 🧪 and mentored undergraduate and master’s students 🎓. Skilled in handling rats, mice, and insects 🐭🦗, Dr. Al-Tamimi is also proficient in advanced molecular biology, immunology, and physiology techniques 🧬🔬.

Awards

Dr. Jameel Al-Tamimi 🎓 has been recognized for his academic excellence with several prestigious awards. In 2015, he received an acknowledgment certificate from the Chairman of the Center of Excellence in the Development of Science and Mathematics Education at King Saud University 🏅, highlighting his contribution to scientific advancement. Earlier, in 2013, he was honored with a Certificate of Appreciation (General Prize) during the first Graduate Student Annual Scientific Meeting at KSU 📜🎉. These achievements reflect his dedication to academic excellence, innovation in research, and commitment to the scientific community 🌟📚.

Research Focus

Dr. Jameel Al-Tamimi is a multidisciplinary biomedical researcher whose primary focus lies in oxidative stress, wound healing, diabetes, and nanoparticle therapeutics. His work spans nanomedicine, immunomodulation, and natural product pharmacology, particularly in evaluating the biological activities of camel milk peptides, selenium and zinc oxide nanoparticles, and bioactive plant extracts. Dr. Al-Tamimi’s studies contribute significantly to redox biology, diabetic complications, and biofabrication of therapeutic agents, offering innovative strategies for combating chronic diseases and enhancing healing processes. 🧫💊🐫 His collaborative work reflects a strong emphasis on toxicology, regenerative medicine, and bio-nanotechnology.

Publication Top Notes

Camel milk peptide improves wound healing in diabetic rats by orchestrating the redox status and immune response

Wound healing of different molecular weight of hyaluronan; in-vivo study‏

Folic acid and melatonin mitigate diabetic nephropathy in rats via inhibition of oxidative stress‏

Synthesis, structural characterization of silver (I)-NHC complexes and their antimicrobial, antioxidant and antitumor activities‏

Potential effects of the combination of nicotinamide, vitamin B2 and vitamin C on oxidative-mediated hepatotoxicity induced by thioacetamide‏

Efficacy of a Methanolic Extract of Adansonia digitata Leaf in Alleviating Hyperglycemia, Hyperlipidemia, and Oxidative Stress of Diabetic Rats‏

Antioxidant Bioactivity of Samsum Ant (Pachycondyla sennaarensis) Venom Protects against CCL4‐Induced Nephrotoxicity in Mice‏

Biofabrication of Zinc Oxide Nanoparticle from Ochradenus baccatus Leaves: Broad‐Spectrum Antibiofilm Activity, Protein Binding Studies, and In Vivo Toxicity …‏

Charbel Fadel | Pharmacology | Best Researcher Award

Published on by Top Pharmaceutical

Charbel Fadel | Pharmacology | Best Researcher Award

Dr. Charbel Fadel, University of Pisa, Italy

Dr. Charbel Fadel is a renowned researcher in Veterinary Pharmacology with a PhD from the University of Sassari, Italy. He specializes in pharmacotherapy, quality control, and pharmacokinetics. Currently, Dr. Fadel is a Research Fellow at the University of Pisa, Italy, overseeing pharmacology lab operations and conducting animal studies. With a rich background in veterinary medicine, he has contributed to numerous scientific publications and presented at prestigious international conferences. Dr. Fadel’s work is focused on drug disposition, antimicrobial resistance, and improving veterinary pharmacology practices globally. He holds multiple honors and continues to impact veterinary science.

Publication Profile

Scopus

Education

Dr. Charbel Fadel is a distinguished veterinarian with extensive academic qualifications. He earned his Ph.D. in Veterinary Pharmacology, Pharmacotherapy, and Quality Control from the University of Sassari, Italy, in October 2023. Prior to this, he completed a Master’s degree in Veterinary Medicine, specializing in Small Animals’ Medicine, at L’Université Libanaise, Lebanon, in October 2020. His expertise in veterinary pharmacology and small animal care, combined with a passion for enhancing animal health, defines his professional journey.

Experience

Dr. Charbel Fadel has a rich professional background in veterinary medicine. Currently, he serves as a Research Fellow in Veterinary Pharmacology at the University of Pisa, Italy, where he oversees lab operations, manages pharmacokinetic studies, and collaborates with international teams to refine pharmacotherapy strategies. Before this, he was the Project and Operations Manager at IVet Medical in Beirut, Lebanon. In this role, he provided expert guidance to veterinarians on the use of biomedical machines, biological tests, and surgical instruments, while also managing the procurement and evaluation of medical supplies.

Awards

Dr. Charbel Fadel has earned numerous honors throughout his career. He has been an active reviewer for the Journal of Veterinary Pharmacology and Therapeutics since 2023 and was awarded the “Cultore della Materia” honor by the University of Pisa in January 2024 for his work as a Subject Specialist/Adjunct Lecturer. He received second runner-up for the 2023 JVPT Paper Award from Wiley Publishers, and his article on robenacoxib pharmacokinetics was recognized as the most cited in 2022-2023. Dr. Fadel also contributed to the “Rocinate Program” and completed several veterinary training programs in Russia.

Research Focus

Dr. Charbel Fadel’s research focus lies in veterinary pharmacology, particularly in the comparative pharmacokinetics of various drugs in livestock species like sheep and goats. His studies, including those on metronidazole and omeprazole, aim to enhance the understanding of drug absorption, distribution, metabolism, and excretion in these animals. This research is crucial for optimizing veterinary care and ensuring effective medication dosages in different animal species. Dr. Fadel’s work supports the development of more tailored and efficient treatment protocols for livestock, contributing to both animal health and agricultural practices.

Publication Top Notes

Comparative pharmacokinetic evaluation of metronidazole in sheep and goats

Comparative Pharmacokinetics of Intravenous and Subcutaneous Omeprazole in Sheep and Goats

Daotong Li | Psychopharmacology | Best Researcher Award

Published on by Top Pharmaceutical

Daotong Li | Psychopharmacology | Best Researcher Award

Prof. Dr. Daotong Li, China Agricultural University, China

Prof. Dr. Daotong Li is an Associate Professor at China Agricultural University’s College of Food Science and Nutritional Engineering. His research focuses on dietary nutrition, gut microbiota, and food-medicine homology. He has led national research projects and published in top-tier journals like Science Bulletin, Microbiome, and Critical Reviews in Food Science and Nutrition, with over 800 citations and two ESI Highly Cited Papers. 🌱🧬 He has served as Secretary of the International Association of Dietetic Nutrition and Safety and was honored as an “Outstanding Talent” by China Agricultural University in 2022.

Publication Profile

Scopus

Education

Prof. Dr. Daotong Li has an impressive academic background spanning multiple disciplines and institutions. He earned his Ph.D. in Agricultural Products Processing and Storage Engineering from China Agricultural University (2015–2019), with a joint Ph.D. training in Immunology at the renowned Weizmann Institute of Science in Israel (2017–2018) 🌍🔬. Earlier, he completed his Master’s degree in Basic Veterinary Science at South China Agricultural University (2011–2014) 🐾, following a Bachelor’s degree in Animal Inspection and Quarantine from Shanxi Agricultural University (2007–2011) 🐄📘. His diverse educational journey reflects a deep commitment to advancing agricultural and biomedical sciences.

Experience

Prof. Dr. Daotong Li brings valuable experience in both academia and research. Since October 2022, he has been serving as an Associate Professor at the College of Food Science and Nutritional Engineering, China Agricultural University 🏫🥼. Prior to this, from September 2019 to September 2022, he worked as a Postdoctoral Researcher at the School of Basic Medical Sciences, Peking University 🔬🧠. His professional journey highlights a strong dedication to scientific advancement in food science, nutrition, and medical research, positioning him as a key contributor in these interdisciplinary fields .

Awards

Prof. Dr. Daotong Li has received prestigious recognitions for his academic excellence and research contributions. In 2019, he was honored as a “Boya Postdoctoral Fellow” by Peking University, a testament to his outstanding performance during his postdoctoral studies 🔬🎓. Later, in 2022, he was recognized as an “Outstanding Talent” by China Agricultural University 🌟🏫, reflecting his impactful work in food science and nutritional engineering. These accolades not only highlight his dedication to scientific research but also his rising influence in the academic community .

Research Focus

Prof. Dr. Daotong Li focuses on functional foods, nutritional biochemistry, and phytochemistry, with an emphasis on the health benefits of plant-derived compounds. His research explores the nutritional and therapeutic values of superfoods like quinoa 🧡, Houttuynia cordata 🌿, and the sustainable use of fruit and vegetable residues 🍊🥦. He also investigates gut microbiota 🦠, particularly how compounds like acrylamide affect intestinal health and conditions like colitis. His interdisciplinary work spans food science, toxicology, and natural product chemistry, contributing to advancements in functional nutrition 🍽️, sustainable food systems ♻️, and plant-based therapeutics .

Publication Top Notes

Quinoa: Nutritional and phytochemical value, beneficial effects, and future applications

Acrylamide drives amidase-mediated gut dysbiosis to aggravate colitis

The nutritional value, application status and challenges of Houttuynia cordata Thunb (H. cordata)

Sustainable Extraction Technology of Fruit and Vegetable Residues as Novel Food Ingredients